# KARL STORZ proposes to acquire Asensus Surgical for $0.35 per share

Asensus Surgical has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG for KARL STORZ to acquire 100% of Asensus common stock for $0.35 per share in cash, representing a 66.7% premium. A bridge loan of up to $20 million has been provided.

- Type: Acquisition
- Announced: 2024-04-03
- Where: Research Triangle Park, North Carolina, United States
- Status: rumored
- Products: surgical robotics, digital surgery platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Asensus Surgical](https://endata.com/companies/68616.md) (target)
- [KARL STORZ SE & Co. KG](https://endata.com/companies/76612.md) (acquirer)

## Sources

- [business.newportvermontdailyexpress.com](http://business.newportvermontdailyexpress.com/newportvermontdailyexpress/article/gnwcq-2024-4-3-asensus-surgical-inc-announces-non-binding-acquisition-proposal-and-exclusivity-arrangement-with-karl-storz-se-and-co-kg), 2024-04-03: "KARL STORZ has communicated that the proposed purchase price represents its 'best and final' offer to the Company."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.